Promethazine, first known as 3,277 R.P., is an N-dimethylaminopropyl derivative of [phenothiazine] that was developed in France in 1946. Promethazine antagonizes a variety of receptors, allowing it to be used for a number of indications including allergic reactions, pain, sedation, nausea, and vomiting. Promethazine was granted FDA approval before 29 March 1951. It is grouped under the following drug class(es): Hypnotics and Sedatives. Its therapeutic use is listed as adhesion-prevention agents and antihistamines. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Proazamine, Protazine, Promethazin and Prometazin. Its PubChem CID is 4927.
Promethazine
| CAS No | 60-87-7 |
|---|---|
| Molecular Formula | C17H20N2S |
| Molecular Weight | 284.4 g/mol |
| Synonyms | N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
, is an N-dimethylaminopropyl derivative of [phenothiazine] that was developed in France in 1946. Promethazine antagonizes a variety of receptors, allowing it to be used for a number of indications including allergic reactions, pain, sedation, nausea, and vomiting.
The listed CAS number is 60-87-7.
The listed molecular formula is C17H20N2S.
The listed molecular weight is 284.4 g/mol.
N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine.
The source lists Proazamine, Protazine, Promethazin and Prometazin.